Deborah Kilpatrick
InvestorPartner at Sonder Capital · Health IT CEO, Evidation; Member, Material Impact Entrepreneurial Advisory Board at Material Impact
San Francisco Bay Area
About
Co-founder and CEO of digital health company Evidation Health and a member of Material Impact's entrepreneurial advisory board since Fund I. She previously served as Chief Commercial Officer of genomic diagnostics firm CardioDx and held R&D and new ventures leadership roles at Guidant Corporation's Vascular Intervention Division.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Experience
- Sonder CapitalPartner, Sonder Capitalcurrent2024 — presentSan Francisco Bay Area
- Sutter HealthBoard of Directors, Sutter Healthcurrent2024 — presentSan Francisco Bay Area
- Jupiter EndovascularBoard of Directors, Jupiter Endovascularcurrent2025 — presentSan Francisco Bay Area
- Cordance MedicalBoard of Directors, Cordance Medicalcurrent2025 — presentSan Francisco Bay Area
- NextGen Jane, Inc.Board of Directors & Investor, NextGen Janecurrent2019 — presentSan Francisco Bay Area
- GXLAdvisorcurrent2025 — presentSan Francisco Bay Area
- MedtechWomenCo-Founder & Board Director, MedtechWomencurrent2010 — presentSan Francisco Bay Area
- Stanford Byers Center for BiodesignInnovation Team Coach, Stanford University Biodesign Fellows Programcurrent2019 — presentPalo Alto, California, United States
- Fogarty Institute for InnovationFerolyn Fellowship Advisory Boardcurrent2019 — presentSan Francisco Bay Area
- EvidationExecutive Chair of the Board (2020-2024), co-CEO (2020-2023), Chief Executive Officer (2014-2020)2014 — 2024San Francisco Bay Area
- Georgia Institute of TechnologyGeorgia Tech College of Engineering Advisory Board (former Chair)2004 — 2024Atlanta, Georgia
- The Task Force for Global Health, Inc.Board of Directors, The Task Force for Global Health2019 — 2023Atlanta, GA
- California Polytechnic State UniversityCal Poly College of Engineering Advisory Board2019 — 2022San Luis Obispo, California Area
- CardioDxVP Market Development, SVP Commercial2006 — 2012San Francisco Bay Area
- Boston ScientificDirector, New Ventures & Therapy Development; Research Fellow (Guidant, Vascular Intervention Group)1997 — 2006San Francisco Bay Area
- ExponentSenior Biomechanics Engineer1996 — 1998
- Georgia Institute of TechnologyBioengineering Graduate Research Fellow and ARCS Scholar, Woodruff School of Mechanical Engineering1991 — 1996
- Pratt & WhitneyStructures and Aeroelasticity Engineer1989 — 1991
Skills & more
Medical Devices99R&D55Cardiology43Strategic Planning33Commercialization81Lifesciences15Product Management18Healthcare21Biomedical Engineering13Business Development20Business Strategy10Competitive Intelligence2
+12 more
Cross-functional Team LeadershipEntrepreneurshipHardware DiagnosticsISO 13485LeadershipProgram ManagementStart-upsStrategyVascularLife SciencesMergers & AcquisitionsProduct LaunchFrom Deborah's professional profile.
Investments
Board seats
Jupiter EndovascularNextGen Jane, Inc.Sleep Number (NASDAQ: SNBR)
Per the firm's website.
Colleagues at Sonder Capital
Andy McGibbon
Operating Advisor at Sonder Capital
Andy Weiss
Operating Advisor at Sonder Capital
Colby Wood
Co-Founder and Partner at Sonder Capital
Dan Azagury
Clinical Advisor at Sonder Capital
Fred Moll
Co-Founder and Partner at Sonder Capital
Grant Heidrich
Fund Advisor at Sonder Capital
Jay Watkins
Co-Founder and Partner at Sonder Capital
Joe Mandato
Operating Advisor at Sonder Capital
Frequently asked questions
- Who is Deborah Kilpatrick?
- Co-founder and CEO of digital health company Evidation Health and a member of Material Impact's entrepreneurial advisory board since Fund I. She previously served as Chief Commercial Officer of genomic diagnostics firm CardioDx and held R&D and new ventures leadership roles at Guidant Corporation's Vascular Intervention Division.
- Where does Deborah Kilpatrick work?
- Deborah Kilpatrick is Partner at Sonder Capital.
- What does Deborah Kilpatrick invest in?
- Deborah Kilpatrick invests in AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- What boards does Deborah Kilpatrick sit on?
- Deborah Kilpatrick holds tracked board seats at Jupiter Endovascular, NextGen Jane, Inc., Sleep Number (NASDAQ: SNBR).
- Where did Deborah Kilpatrick go to school?
- Deborah Kilpatrick studied at Georgia Institute of Technology (PhD, Mechanical Engineering/Bioengineering major focus); Georgia Institute of Technology (MS, Mechanical Engineering); Georgia Institute of Technology (BS, Engineering Science & Mechanics with High Honor. Tau Beta Pi).
Same school
Also attended Georgia Institute of Technology346
Brando De CourtenData Engineer at P101 VenturesTom DyalCo-Founder at Redpoint VenturesWouter Van de PutteInvestment Director at Capricorn Venture PartnersWill McGinnisEntrepreneur and data science executive working at the intersection of AI/ML, technology, and business strategyJaya GuptaInvestor at Foundation CapitalJames WangGeneral Partner at Creative Ventures
+ 340 more
Shared employers
Also worked at Sutter Health11
Dr. Shadi BatahResearch / Founder Relations at Transform Capital ManagementJim HickmanVenture Partner at Suncoast VenturesLyla YoussefAssociate at SR One Capital ManagementLaura WiltExecutive Advisor at LRVHealthAlex EfronSenior Associate at Telegraph Hill PartnersStephanie BousheriVenture Advisor at Pier 70 Ventures
+ 5 more
Also worked at Cordance Medical2
Also worked at Stanford Byers Center for Biodesign21
Dr Ruchi DanaPartner at MFV PartnersRohini KosogluVenture Partner at FusionDr. Ryan SpitlerAdvisory Partner at Boutique Venture PartnersAuriel AugustPrincipal at Sante VenturesKate GarrettCo-Founder and Managing Partner at Sonder CapitalMarta G. ZanchiManaging Partner at Nina Capital
+ 15 more
Also worked at Boston Scientific46
Ben CoughlanInvestor at Moonfire VenturesRobin BorgInvestor at TRANSFORMATION CAPITALTroy BurtonHead of Product at Red Cell IncubationRache SimmonsBreast Cancer Surgeon at FemHealth VenturesChris ShanahanPrincipal at DFJDavid ThompsonGeneral Partner at 415 Capital
+ 40 more